General anesthesia gastroscopy
Conditions
Interventions
control group 1:total propofol
R2 group 1:propofol+remifentanil2 ng/ml
R4 group 1:propofol+remifentanil4 ng/ml
R6 group 1:propofol+remifentanil6 ng/ml
R8 group 1:propofol+remifentanil8 ng/ml
control group 2:total propofol
R2 group 2:propofol+remifentanil2 ng/ml
R4 group 2:propofol+remifentanil4 ng/ml
R6 group 2:propofol+remifentanil6 ng/ml
R8 group 2:propofol+remifentanil8 ng/ml
Sponsors
Shenzhen third People's hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists physical status I–II patients aged 18-60 years, and undergoing general anesthesia gastroscopy
Exclusion criteria
Exclusion criteria: Patients with active upper gastrointestinal bleeding, anemia, platelet count < 50 x 10^9/L, important organ system dysfunction, allergic to propofol or opioids, suffering from mental illness, or using a history of mental illness and drug or having infection in the monitoring site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IOC2 and its lowest level; effective time of IOC2;effective time of IOC1 and BIS;cooreationship between IOC2 and remifentanil; | — |
Secondary
| Measure | Time frame |
|---|---|
| IOC1 and its lowest level;BIS and its lowest level; | — |
Countries
China
Contacts
Public ContactLIU Minqiang
Shenzhen third People's hospital
Outcome results
None listed